1 Min Read
LONDON, Dec 17 (Reuters) - GlaxoSmithKline Plc : * Announced today that the U.S. food and drug administration (FDA) has approved
fluarix quadrivalent * Will make fluarix quadrivalent available in time for the 2013-14 flu season
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.